These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26758946)

  • 21. Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes.
    Elfakhani M; Torabi S; Hussein D; Mills N; Verbeck GF; Mo H
    Exp Biol Med (Maywood); 2014 Mar; 239(3):293-301. PubMed ID: 24477821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The mitochondrial unfolded protein response activator ATFS-1 protects cells from inhibition of the mevalonate pathway.
    Rauthan M; Ranji P; Aguilera Pradenas N; Pitot C; Pilon M
    Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5981-6. PubMed ID: 23530189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy inhibits fatty acid synthase via dynamic protein modifications.
    Trub AG; Wagner GR; Anderson KA; Crown SB; Zhang GF; Thompson JW; Ilkayeva OR; Stevens RD; Grimsrud PA; Kulkarni RA; Backos DS; Meier JL; Hirschey MD
    Nat Commun; 2022 May; 13(1):2542. PubMed ID: 35538051
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes.
    Massonnet B; Normand S; Moschitz R; Delwail A; Favot L; Garcia M; Bourmeyster N; Cuisset L; Grateau G; Morel F; Silvain C; Lecron JC
    Eur Cytokine Netw; 2009 Sep; 20(3):112-20. PubMed ID: 19825520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metabolic Induction of Trained Immunity through the Mevalonate Pathway.
    Bekkering S; Arts RJW; Novakovic B; Kourtzelis I; van der Heijden CDCC; Li Y; Popa CD; Ter Horst R; van Tuijl J; Netea-Maier RT; van de Veerdonk FL; Chavakis T; Joosten LAB; van der Meer JWM; Stunnenberg H; Riksen NP; Netea MG
    Cell; 2018 Jan; 172(1-2):135-146.e9. PubMed ID: 29328908
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia.
    Ermini L; Post M; Caniggia I
    Curr Mol Pharmacol; 2017; 10(2):152-160. PubMed ID: 26758951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR; Anel RL; Zeng L; Lomasney J; Sahai A; Kanwar YS
    Arch Immunol Ther Exp (Warsz); 2003; 51(3):139-48. PubMed ID: 12894868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of pleiotropic effects of statins in dementia.
    Crisby M
    Acta Neurol Scand Suppl; 2006; 185():115-8. PubMed ID: 16866920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-cancer therapy: targeting the mevalonate pathway.
    Swanson KM; Hohl RJ
    Curr Cancer Drug Targets; 2006 Feb; 6(1):15-37. PubMed ID: 16475974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Conserved statin-mediated activation of the p38-MAPK pathway protects Caenorhabditis elegans from the cholesterol-independent effects of statins.
    Goncalves IL; Tal S; Barki-Harrington L; Sapir A
    Mol Metab; 2020 Sep; 39():101003. PubMed ID: 32339771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mevalonate-suppressive dietary isoprenoids for bone health.
    Mo H; Yeganehjoo H; Shah A; Mo WK; Soelaiman IN; Shen CL
    J Nutr Biochem; 2012 Dec; 23(12):1543-51. PubMed ID: 22981371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Posttranscriptional regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in lens epithelial cells by mevalonate-derived nonsterols.
    Cenedella RJ
    Exp Eye Res; 1997 Jul; 65(1):63-72. PubMed ID: 9237866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines.
    Palozza P; Colangelo M; Simone R; Catalano A; Boninsegna A; Lanza P; Monego G; Ranelletti FO
    Carcinogenesis; 2010 Oct; 31(10):1813-21. PubMed ID: 20699249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.
    Gabor KA; Fessler MB
    Curr Mol Pharmacol; 2017; 10(1):27-45. PubMed ID: 26758950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMG-CoA reductase inhibitors and coenzyme Q10.
    Nawarskas JJ
    Cardiol Rev; 2005; 13(2):76-9. PubMed ID: 15705257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle-specific HMG-CoA reductase knockout mice exhibit rhabdomyolysis: A model for statin-induced myopathy.
    Osaki Y; Nakagawa Y; Miyahara S; Iwasaki H; Ishii A; Matsuzaka T; Kobayashi K; Yatoh S; Takahashi A; Yahagi N; Suzuki H; Sone H; Ohashi K; Ishibashi S; Yamada N; Shimano H
    Biochem Biophys Res Commun; 2015 Oct; 466(3):536-40. PubMed ID: 26381177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HMG-CoA reductase inhibition reduces the proinflammatory activation of human vascular smooth muscle cells by the terminal complement factor C5b-9.
    Viedt C; Shen W; Fei J; Kamimura M; Hänsch GM; Katus HA; Kreuzer J
    Basic Res Cardiol; 2003 Nov; 98(6):353-61. PubMed ID: 14556080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma.
    Clendening JW; Pandyra A; Li Z; Boutros PC; Martirosyan A; Lehner R; Jurisica I; Trudel S; Penn LZ
    Blood; 2010 Jun; 115(23):4787-97. PubMed ID: 20360469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse effects of statins - mechanisms and consequences.
    Bełtowski J; Wójcicka G; Jamroz-Wiśniewska A
    Curr Drug Saf; 2009 Sep; 4(3):209-28. PubMed ID: 19534648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.